bioRxivMicrobiologyPreprint
Differential development of antibiotic resistance and virulence between Acinetobacter species
E. M. Darby, R. A. Moran, E. Holden, T. Morris, F. Harrison, B. Clough, R. S. McInnes, L. Schneider, E. M. Frickel, M. A. Webber, J. M. A. Blair
Abstract
The two species that account for most cases of Acinetobacter-associated bacteraemia in the UK are Acinetobacter lwoffii, often a commensal but also an emerging pathogen, and A. baumannii, a well-known antibiotic-resistant species. While these species both cause similar types of human infection and occupy the same niche, A. lwoffii (unlike A. baumannii) has thus far remained susceptible to antibiotics. Comparatively little is known about the biology of A. lwoffii and this is the largest study on it conducted to date, providing valuable insights into its behaviour and potential threat to human health. This study aimed to explain the antibiotic susceptibility, virulence, and fundamental biological differences between these two species. The relative susceptibility of A. lwoffii, was explained as it encoded fewer antibiotic resistance and efflux pump genes than A. baumannii (9 and 30 respectively). While both species had markers of horizontal gene transfer, A. lwoffii encoded more DNA defence systems and harboured a far more restricted range of plasmids. Furthermore, A. lwoffii displayed a reduced ability to select for antibiotic resistance mutations, form biofilm and infect both in vivo and in vitro models of infection. This study suggests that the emerging pathogen A. lwoffii has remained susceptible to antibiotics because mechanisms exist to make it highly selective about the DNA it acquires, and we hypothesise that the fact that it only harbours a single RND system restricts the ability to select for resistance mutations. This provides valuable insights into how development of resistance can be constrained in Gram negative bacteria. ImportanceAcinetobacter lwoffii is often a harmless commensal but is also an emerging pathogen and is the most common cause of Acinetobacter-derived blood stream infections in England and Wales. In contrast to the well-studied, and often highly drug resistant A. baumannii, A. lwoffii has remained susceptible to antibiotics. This study explains why this organism has not evolved resistance to antibiotics. These new insights are important to understand why and how some species develop antibiotic resistance, while others do not and could inform future novel treatment strategies.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Correlation analysis between drug resistance and virulence genes of carbapenem-resistant Acinetobacter baumannii In Western Guilin
- Phylogenomic and phenotypic analyses highlight the diversity of antibiotic resistance and virulence in both human and non-human Acinetobacter baumannii
E. Sykes, V. Mateo-Estrada, … A. Kumar·bioRxiv·Dec 13, 2023
- Monitoring the battlefield: Antimicrobial resistance, antibiofilm patterns and virulence factors of Acinetobacter baumannii isolates from hospital system
S. Awuor·bioRxiv·Dec 14, 2022
- Evidence for high-frequency parallel evolution in virulent A. baumannii cultures
Jonathon Mclaughlin, John K. Tobin, … Stephen J. Dollery·bioRxiv·Oct 22, 2024
- Lipidomics and colistin resistance in non-human isolates of Acinetobacter seifertii
Ellen M. E. Sykes, Valeria Mateo-Estrada, … Ayush Kumar·bioRxiv·May 22, 2024
- Immunosuppression broadens evolutionary pathways to treatment failure during Acinetobacter baumannii pneumonia
W. Huo, L. M. Busch, … R. R. Isberg·bioRxiv·Apr 7, 2021